Health leads to economic productivity and prosperity and is important for the well-being of society. To advance a more personalised, patient-centred approach and offer affordable health care, effective and evidence-based policy is imperative.

Technopolis Group supports policy makers and programme managers to develop goal-oriented agendas. Our consultants help to carefully weigh up the cost, effects and impacts of the strategy and investments in health, science, technology and innovation. With our in-depth knowledge of health and life sciences and extensive experience in strategic planning and evaluation, we strive to contribute to effective policy making for better health.

The impact of collaboration: the value of UK medical research to EU science and health

The UK has a strong medical research community; the country’s withdrawal from the European Union (EU) can therefore be expected to have implications not only for the UK, but also for EU science and health. To better understand the UK’s contribution to medical research and patient health in the EU, a new study was commissioned…

View report

Review of the Product Development Partnerships Fund 2011-2014

Every year, poverty related diseases affect millions of people in the developing world. Yet, in the absence of clear profit potential, pharmaceutical companies are reluctant to invest in the development of treatments to fight these diseases. In response to this market failure, in the mid-1990s Product Development Partnerships (PDPs) emerged. PDPs use private sector approaches…

View report

Assessment of the performance and impact of the first programme of the European & Developing Countries Clinical Trials Partnership (EDCTP)

The European & Developing Countries Clinical Trials Partnership (EDCTP) was created in 2003 in response to the global health crisis caused by the three main poverty-related diseases HIV/AIDS, tuberculosis and malaria. The first EDCTP programme was aimed at accelerating the development of new or improved drugs, vaccines, microbicides and diagnostics against these three diseases. EDCTP…

View report

Assessing the research potential of access to clinical trial data

Clinical trials generate systematic and vital information about the efficacy, safety and quality of medical interventions. However, there has been much discussion about the degree to which trial results and the underpinning data are currently made available to researchers outside of the team that conducted the original trial. The primary aims of this study, commissioned…

View report
View more